Pharmacological Basis for Use of Armillaria mellea Polysaccharides in Alzheimer’s Disease: Antiapoptosis and Antioxidation

Figure 1

(a) The preparation of polysaccharides isolated from A. mellea mycelium obtained via submerged fermentation. (b) The process of AlCl₃ combined with D-gal-induced Alzheimer’s disease mouse model establishment and drug administration.

(a)

(b)